Chronic obstructive pulmonary disease (COPD) is not curable, but can be managed with appropriate medication. Various awareness programs have been initiated by healthcare providers and health organisations/societies such as environmental programs, medication maintenance programs and online education programs for public and healthcare professionals, which encourage people to adopt early medication. This factor is expected to play a key role in increased revenue of the global respiratory devices market over the forecast period. Healthcare providers and organisations are teaming up to improve and prevent respiratory diseases across the globe. AstraZeneca and 10 industry leaders are teaming up to prevent and control prevalence of respiratory disease in China.
Improvement in healthcare policies in various countries, such as the U.S., has enhanced the affordability for various diagnostic and treatment services, and in turn amplified the life expectancy of the people. The burgeoning ageing population will raise the number of people diagnosed with COPD and asthma. Overall management of asthma and COPD is very crucial and problematic after 65 years of age. People above 65 years who are diagnosed with asthma and COPD are unable to consume liquid medication. Airway clearances are thus turning out to be the ultimate choice as they convert liquid medication into aerosol or mist. Moreover, the rise in per capita income is influencing individuals to spend more on health care, as concerns regarding healthcare is increasing with increasing living standards. The other factors that are benefiting the North America airway clearance systems market are the expansion of third-party payer coverage by manufacturers, growth of home care and institutional market, high incidence rate of chronic diseases, employment of the Affordable Care Act, and the lowering cost of the treatment settings. However, it is yet to be seen that whether the strict regulation scenario act as a hurdle or not.

Market Analysis and Insights: Global Airway Clearance Systems Market
The global Airway Clearance Systems market size is projected to reach US$ 355.8 million by 2027, from US$ 260.8 million in 2020, at a CAGR of 4.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Airway Clearance Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Airway Clearance Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Airway Clearance Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Airway Clearance Systems market.

Global Airway Clearance Systems Scope and Market Size
Airway Clearance Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Airway Clearance Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Positive Expiratory Pressure (PEP)
Oscillatory Positive Expiratory Pressure (OPEP)
High Frequency ChestWall Compression
Intrapulmonary Percussive Ventilation
Mechanical Cough Assist

Segment by Application
Cystic Fibrosis
Chronic Bronchitis
Bronchiectasis
Immotile Cilia Syndrome
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Hill Rom
PARI
Electromed
Philips Respironics